Press Releases

Date	Title	View
August 13, 2024	Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update	PDF Version
May 29, 2024	Enliven Therapeutics to Present at Two Upcoming Investor Conferences	PDF Version
May 14, 2024	Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update	PDF Version
April 11, 2024	Enliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia	PDF Version
April 9, 2024	Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors	PDF Version
March 28, 2024	Enliven Therapeutics to Share Initial Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 and Host Virtual Key Opinion Leader Event on April 11, 2024	PDF Version
March 19, 2024	Enliven Therapeutics Announces $90 Million Private Placement Financing and Provides Pipeline Updates	PDF Version
March 14, 2024	Enliven Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update	PDF Version
February 27, 2024	Enliven Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference	PDF Version